Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
MANKIND.NSthis companyMankind Pharma Limited	₹2,668.30	43.28×	5.08×	5.8×	22.97×	-54.4%	43.1%	19.1%	13.4%	11.7%	9.1%	2.3%	0.39×	1.51×	4.27×	1.07×	0.0%	6	6.53	3	B
AJANTPHARM.NSAjanta Pharma Limited	₹3,344.00	33.18×	7.74×	6.43×	22.46×	64.5%	51.4%	24.3%	19.4%	23.3%	20.5%	0.4%	0.06×	0.1×	82.23×	2.64×	1.0%	5	18.51	4	A
ALKEM.NSAlkem Laboratories Limited	₹5,398.50	27.24×	4.54×	4.26×	18.9×	35.0%	65.4%	17.8%	15.6%	16.7%	12.5%	2.1%	0.15×	0.53×	16.32×	2.55×	1.0%	3	—	2	B-
AUROPHARMA.NSAurobindo Pharma Limited	₹1,855.30	21.62×	2×	2.25×	10.17×	130.3%	39.2%	15.1%	10.4%	9.2%	7.3%	3.7%	0.21×	-0.25×	13.22×	1.81×	0.3%	5	—	2	B-
CIPLA.NSCipla Limited	₹1,403.80	25.49×	2.87×	3.51×	15.19×	112.4%	42.7%	16.7%	13.8%	11.3%	9.8%	2.6%	0.02×	-0.06×	86.67×	3.44×	1.3%	4	9.92	4	A-
DRREDDY.NSDr. Reddy's Laboratories Limited	₹1,385.00	24.38×	2.77×	3.11×	14.13×	25.1%	52.8%	13.8%	12.8%	11.4%	7.5%	2.9%	0.24×	0.94×	12.42×	1.8×	0.6%	7	5.66	3	B+
Peer median	—	25.49×	2.87×	3.51×	15.19×	64.5%	51.4%	16.7%	13.8%	11.4%	9.8%	2.6%	0.15×	0.1×	16.32×	2.55×	1.0%	5	9.92	3	—